Stockreport

4D Molecular Therapeutics: Market Expects Wet AMD Gene Therapy Failure - I'm Not So Sure [Seeking Alpha]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF Investing Group Leader Follow Play 14min Summary 4D Molecular Therapeutics' lead candidate, 4D-150, aims to provide a one-time gene therapy for Wet-AMD, showi [Read more]